Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity.
Pulmonary surfactant biophysical properties are best described by surface tension and surface viscosity. Besides lecithin, surfactant contains a variety of minor lipids, such as plasmalogens, polyunsaturated fatty acid-containing phospholipids (PUFA-PL), and cholesterol. Plasmalogens and cholesterol improve surface properties of lipid mixtures significantly. High PUFA-PL and plasmalogen content in tracheal aspirate of preterm infants reduces the risk of developing chronic lung disease. Different preparations are available for exogenous surfactant substitution; however, little is known about lipid composition and surface viscosity. Thus lipid composition and surface properties (measured by oscillating drop surfactometer) of three commercial surfactant preparations (Alveofact, Curosurf, Survanta) were compared. Lipid composition exhibited strong differences: Survanta had the highest proportion of disaturated PL and total neutral lipids and the lowest proportion of PUFA-PL. Highest plasmalogen and PUFA-PL concentrations were found in Curosurf (3.8 +/- 0.1 vs. 26 +/- 1 mol%) compared with Alveofact (0.9 +/- 0.3 vs. 11 +/- 1) and Survanta (1.5 +/- 0.2 vs. 6 +/- 1). In Survanta samples, viscosity increased >8 x 10(-6) kg/s at surface tension of 30 mN/m. Curosurf showed only slightly increased surface viscosity below surface tensions of 25 mN/m, and viscosity did not reach 5 x 10(-6) kg/s. By adding defined PL to Survanta, we obtained a Curosurf-like lipid mixture (without plasmalogens) that exhibited biophysical properties like Curosurf. Different lipid compositions could explain some of the differences in surface viscosity. Therefore, PL pattern and minor surfactant lipids are important for biophysical activity and should be considered when designing synthetic surfactant preparations.
Rüdiger
Mario
M
Clinic for Neonatology, Charité-Mitte; Schumannstr. 21, 10098 Berlin, Germany.
Tölle
Angelika
A
Meier
Wolfgang
W
Rüstow
Bernd
B
D000818:Animals; D001688:Biological Products / Q000737:chemistry*; D002417:Cattle; D008055:Lipids / Q000032:analysis* / Q000737:chemistry*; D009994:Osmolar Concentration; D010743:Phospholipids / Q000737:chemistry*; D013552:Swine; D014783:Viscosity
D001688:Biological Products; D008055:Lipids; D010743:Phospholipids; C078272:SF-RI 1, bovine surfactant preparation; C068291:poractant alfa; C072197:beractant